Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

TRANSCAN-3

Financiado

Cerrado

ERA NET Sustained collaboration of national and regional programmes in cancer r...

ERA NET Sustained collaboration of national and regional programmes in cancer research Cancer is a worldwide health burden and a major public health challenge. Despite significant advances in the understanding, prevention, diagnostics and treatment, cancer remains a public health problem in Europe and the world. In... ver más

28/02/2026

Líder desconocido

34M€

Presupuesto del proyecto: 34M€

Líder del proyecto Líder desconocido

Fecha límite participación Sin fecha límite de participación.

Ver 32 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2021-02-02

SC1-HCO-14-2020: ERA-NET: Sustained collaboration of... Specific Challenge:Common challenges in cancer research can only be met by effective transnational c...

I+D

Cerrada hace 4 años

0% 32% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

32 Participantes

MONDRAGON SISTEMAS DE INFORM...

REINGENIERIA DESARROLLOS E I...

NARODOWE CENTRUM BADAN I ROZ...

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 60 meses Fecha Inicio: 2021-02-02
Fecha Fin: 2026-02-28

Líder del proyecto Líder desconocido

Presupuesto del proyecto 34M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Cancer is a worldwide health burden and a major public health challenge. Despite significant advances in the understanding, prevention, diagnostics and treatment, cancer remains a public health problem in Europe and the world. In such a setting, translational cancer research plays a key role in successfully addressing the growing burden of cancer. The great potential of translational cancer research in Europe will only be achieved when the main barriers are systematically addressed through concerted actions between public and private organisations that provide funds for research, researchers, healthcare providers and all those engaged in the cancer research spectrum. Moreover, adequate and systematic financial support backed by a strong political commitment is absolutely essential to help reduce the burden of cancer that European citizens are currently facing. In this context, the TRANSCAN-3 network, with a strong background in funding cancer research, embodies an excellent model of cross-national cooperation by bringing together 31 funding organisations, from 20 countries, with the common goal of supporting high-impact translational cancer research through cross-national joint calls for proposals, and by an efficient investment of dedicated national/regional public funding, leveraged with foundation/charity-based resources and EU financial support. Building up on the well-established cooperation and accomplishments, through the harmonisation of national/regional funding mechanisms and programmes, plus continued and sustained series of efforts for the access to and sharing of data on cancer research, this TRANSCAN-3 project also aims at becoming a catalysts for a sustainable model of funding of high-impact cancer research in Europe and beyond, with an approach to effectively engage relevant stakeholders (patients, society as a whole, policy makers, etc.) in different stages of the action.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores